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Summary.-Growth of isogeneic transplants of a spontaneous murine adenocarci-
noma,which isvirtuallydevoid oftumour-specific transplantation antigens, isinhibi-
ted by i.v. injection of C. parvum 3 days after tumour inoculation, or bymixing a small
dose of C. parvumwiththe tumour inoculum. Moreover, thetherapeutic effect ofcyclo-
phosphamide, followed by i.v. or i.p. injection of C. parvum 5 dayslater, on established
transplants of the same tumour is greater than that of cyclophosphamide alone.
These findings are consistent with the hypothesis that in both situations (i.e. before
the appearance of a palpable tumour and after reduction of an established tumour
transplant with cyclophosphamide) the effect of C. parvum is largely due to activation
of macrophages or macrophage precursors. They have the important practical
implication that adjuvant therapy with C.parvum maybe of value, even with tumours
which are devoid of TSTA.
TUMOURS which arise spontaneously in
mice of strains with a low tumour inci-
dence often appear to be devoid, or almost
devoid, of tumour-specific transplantation
antigens (TSTA).
It has been suggested by Hewitt, Blake
and Walder (1976) that such tumours
provide the only appropriate models for
human cancer, on the grounds that human
tumours are spontaneous. This proposi-
tion seems altogether too extreme since,
as discussed at greater length elsewhere
(Woodruff, 1977a, b) the distinction be-
tween spontaneous and induced tumours
is an operational one, and does not
necessarily reflect important biological
differences. If, as is becoming apparent,
accidental exposure to environmental car-
cinogenic agents of various kinds plays an
aetiological role in many tumours, why
should these tumours differ fundamentally
from tumours deliberately induced with
similar agents in laboratory animals?
Conversely, why should tumours arising
without any obvious environmental cause
in highly inbred strains of animals with a
low incidence of cancer necessarily be a
good model, let alone the only model, for
tumours arising in human populations,
which are extremely heterogeneous in
respect of both their genetic constitution
and the environment in which they live?
We would however agree with Hewitt
et al. (1976) that spontaneous animal
tumours merit more extensive study than
they have hitherto received, and would
ourselves regard them as important models
for investigating the possible existence of
what might perhaps be termed para-
immunological surveillance mechanisms,
i.e. mechanisms which depend on recogni-
tion of neoplastic cells by markers other
than classical surface antigenic deter-
minants, and the response of tumours to
therapeutic procedures which might con-
ceivably augment such mechanisms if,
indeed, they do exist.
The development of a spontaneous
tumour in a mouse of our breeding colony
has provided an opportunity to initiate an
investigation of this kind. The present
paper is concerned with the origin of theM. F. A. WOODRUFF, V. L. WHITEHEAD AND G. SPEEDY
tumour, tests of immunogenicity, and its
response in normal mice to treatment with
C. parvum, which when administered
systemically causes widespread activation
of macrophages, and inhibits the growth
of many tumours, not only in normal mice
(Woodruff and Dunbar, 1973) but also in
thymectomized (Woodruff, Dunbar and
Ghaffar, 1973) and congenitally athymic
mice (Woodruff and Warner, 1977). Fur-
ther experiments, including studies of the
growth of the tumour in athymic mice
and its response to various therapeutic
agents other than C. parrurn will be
reported later.
MATERIALS AND METHODS
Origin and propagation of tumour. The
tumour appeared in the upper pectoral
region of an 11-month-old female CBA/Ca
mouse which had produced 7 litters in the
previous 9 months. The incidence of spon-
taneous tumours in this strain is extremely
low. The mouse was killed when the tumour
was about 12 mm in diameter. The histo-
logical appearance was that of a moderately
well differentiated adenocarcinoma, and was
consistent with a mammary origin. A tumour-
cell suspension was prepared mechanically
without pronase and injected into young
adult CBA mice. When the first generation
transplants were 10-15 mm in diameter, a
cell suspension was prepared from one
mouse; some of this was used to inoculate 3
other mice, and the remainder was frozen
and stored in liquid N2. Further samples
were frozen and stored, and material not
required for this purpose or for serial trans-
plantation was used in experiments.
Preparation ofcell suspensions.-All tumour
cell suspensions wNere prepared with pronase
as previously described (Woodruff and Boak,
1966). They were inoculated s.c. to either the
right or left thigh.
Methods of testing for TSTA. Three
methods were used to assess the immuno-
genicity of the tumour: (1) injection of
viable cells followed by amputation of the
limb into which the cells were injected, (2)
injection of cells which had been irradiated
with a Westinghouse X-ray machine operat-
ing at 220 kV to a dose of 22,000 rad at a rate
of 274 rad/min and (3) injection of cells which
had been incubated for 30 min in Dulbecco
solution containing mitomycin (50 jug mito-
mycin + 2 5 x 106 cells/ml solution) fol-
lowed in each case by live challenge.
Mice.-The tumour transplant recipients
wereyoungadult 18-22 gfemaleCBA/Camice.
C. parvurm. A formalin-killed suspension
of C. acnes strain CN6134 (commonly called
C. parvum CN6134), kindly supplied by The
Wellcome Foundation, was used throughout,
except in one group of control mice wihich
received instead an inactive organism, P.
freudenreichii (NTC 10470), a formalin-
killed culture of which w%as kindly made
available by Dr W. McBride.
The effect of C. parrum on tumour growth
has been tested in twNo ways:
(a) by giving C. parvuin alone i.p., i.v. or
subcutaneously at the site of tumour inocula-
tion (i.t.) 3 days before or after inoculation of
viable tumour cells, ormixedwiththe tumour-
cell inoculum; and
(b) by comparing the response ofestablish-
ed tumour transplants to treatment wNith a
chemotherapeutic agent, cyclophosphamide
(Cy), alone, and in associationwith C. parvum.
Assessment of results.-The effect of
attempts at immunization, and of treatment
before the appearance of a tumour, has been
assessed by comparing the incidence of
tumours and their rate of growth in treated
and control mice. As a rough guide, we have
calculated the mean relative growth rate for
each experimental group, defined as the ratio
of the mean tumour diameter in treated mice
which actually developed tumours to the
mean diameter in the corresponding un-
treated controls at a time when the control
tumours were about 15 mm diameter. When
the difference in behaviour of tumours in
treated and control mice looked as if it might
be significant, the logrank test (Peto et al.,
1977) has been used to calculate the prob-
ability (P) that the difference in respect of
the time taken to attain a particular size
(10 or 15 mm diameter) could be due to
random sampling error. To do this we have
calculated the statistic which Peto et al.
denote by x2 and have followed these authors
in treating x2 as distributed like x2 with one
degree of freedom w%rhen only two groups are
being compared. In comparing the effect of
Cy alone and Cy + C. parvum, w%Ae have relied
on the time taken to attain a particular
tumour diameter, and have again used the
logrank test to assess the significance of the
differences observed.
346EFFECT OF C. PARVUM ON SPONTANEOUS TUMOUR TRANSPLANTS
o
0
O
b~ 0
o
0
X .w4
0
o o
0 CV
14 4I)
PA c
o .
Ca o c,o o ,
5!s,
A
CO
V
14
v
10
C>
tC- s -4 tO t-
-
CA
A
CD Co 10 co C c
10
10 CO CO CO CO CO 10
co Co to g o WO g O Co 0 0 0 0 0 0 0 P- r- P- r- P- r- r- P- r- -4 r-
co 10 co C cO
CO CO
q6
* ;O
GA
¢~~~~~~a EH~~~~~~~~~~1 -~~~~~~~~~~ w
0
a t NV W 0 -4 m CO* = t- 0 -4 o r~~ ~~~~~~- -4- - " ~ -I -I
347
"e
9NM. F. A. WOODRUFF, V. L. WHITEHEAD AND G. SPEEDY
RESULTS
Test of immunogenicity of tumour
The results of attempts to immunize
mice of the strain of origin against the
tumour are summarized in Table I. None
of the procedures tested influenced either
the proportion of mice which developed
tumours in response to challenge with
106, 105 or 104 viable cells, or the relative
growth rate oftumours in mice challenged
with 106 cells. Pretreatment with irradia-
ted cells also had no significant effect on
the relative growth rate in mice challenged
with 105 cells. Pretreatment with viable
cells followed by amputation (Group 7) or
with mitomycin-treated cells (Group 21)
did however result in a modest reduction
in relative growth rate after challenge
with 105 cells, which was significant at the
P = 0 05 level for one or both end points
(10 and 15 mm diameter).
Effect ofC. parvum alone on development of
tumours
The effect of a single dose of C. parvum
given by various routes and at various
times in relation to s.c. injection of 103
viable tumour cells is summarized in
Table II, and details of the 3 experiments
on which this table is based are given in
Table III.
It will be seen that C. parvum (Group 4)
but not P. freudenreichii (Group 5) mixed
with the tumour-cell inoculation had a
marked antitumour effect. A less marked,
but still highly significant, antitumour
effect resulted from i.v. (Group 7) or i.p.
(Group 6) injection of C. parvum 3 days
after tumour inoculation, but not from
injection of C. parvum 3 days before
tumour inoculation (Groups 2 and 3).
Injection of C. parvum on Day 3 at the
site of tumour inoculation (Group 8) was
also ineffective.
Effect of cyclophospharnide (Cy) and C.
parvum on established tumour transplants
The effect of Cy, alone and in associa-
tionwith C.parvum, on established tumour
transplants is summarized in Table IV,
and details of the 3 experiments on which
this Table is based are set out in Table V.
Typical growth curves obtained in these
experiments are illustrated in Figs. 1 and
2; for comparison, growth curves showing
the effect of Cy and C. parvum on trans-
plants of a highly immunogenic methyl-
cholanthrene-induced fibrosarcoma (WI)
are shown in Fig. 3.
TABLE II.-Effect of C. parvum Alone on the Development of W1r54 Tumours.
Pooled Results of 3 Experiments*
Relative Comparison by logrank test with
No. of growth untreated controls in respect of
No. of mice rate in attainment of diameter shown
Treatment mice ( devel- mice - A
(all challenged with 106 chal- oping with 10 mm 15 mm
Group viable tumouir cells on Day 0) leinged tumours tumours x2 p x2 P
1 Nil (Controls) 29 29
2 C.parvunrn0 7 mgi.p. Day -3 12 12 0-92 2-08 >0-10 0 73 >0*30
3 C. parvum 07 mg i.v. Day -3 6 6 0-88 1-32 >020 0-18 >060
4 C. parvum 0-1 mg mixed with
tumour cells Day 0 6 4 0 39 9-43 <0-005 8-32 <0 005
5 P. freudenreichii (10470)
0-1 mg mixed with tumour
cells Day 0 6 6 1-08
6 C. parvum 0 7 mg i.p. Day +3 10 10 0 79 12-04 <0 0005 5-58 <0-02
7 C. parvum 0 7 mg i.v. Day +3 12 12 0-58 13-12t <0 0005 12-14t 0 0005
8 C. parvum 0-1 mg i.t. Day +3 12 12 0 94 0-11 >0 70 0-31 '>0 50
* Detailed results in Table III.
t Obtained by combining the information from Expts B an(i C of Table III (see Methods Section)
348EFFECT OF C. PARVUM ON SPONTANEOUS TUMOUR TRANSPLANTS
0 0
0 QC) ol
0~~~~~~~~~~~~~~~~~~~~~~~~B~~~~~
> w H~~~
oD
C.)
'4-
C3.-0
Co i
0~~~~~db
C.t~~~~~*
~~~~0 a
_I COl
O 0
A A
o0 0 r-
CS o
co 00 co
"
a4
"
Cm Clil
a1
0O 00 m
co) N aq
q cq
t~co 0aI P-
1010 -4 00
P- cq cq eai
0)100O10
c-I 0-? -I1 -
Mcn | O
*-
_ Zs t~f
0¢ 4
O C)
C> O
v v
O VV
la
0
o a o 00
00C>t- 10
V A A
C0
0 oo
0qco o 0 0
AA VVVV
* co C oV i I? r~
" 0a
C'.0 P- *
CoOl4
co CO 01014cqc
q F-4 cq q N '- 1c
t- 00 10 " 0 co10 co
O~= co L' c t- 0 "t'. 10 O CO10
0101 01 C01t 01 01010
0 1
01i O-4c
-0
m '" r410 " c
01 O-
0
01010
r- 0
0)10 0O10 0 xo0010 4-
P-4-I ~ -4 P-4 -4 -4-4- -4 -4 -4 -4
Co Co
A A
1010
Co Co
A A
Co
to 10
Ct "
" o
CO
o _=
Co Co
10
Co o Co Co
10 Co
bo b-0 t0 bD 0
co_ t
-4
0 t t _. .f
c1^
-C)
&I
4V
10 co P- t- P- t-
.
pq ~ 0
349M. F. A. WOODRUFF, V. L. WHITEHEAD AND G. SPEEDY
TABLE IV.-Additive Effect of C. parvum and Cyclophosphamide (Cy) in Treatment
of Established TV54 Tumour Transplants
Was Cr. parvunt + Cy more effective
than Cy alone
_- A _
C. parrum Criterion
attain-
Days ment
Dose after of
(mg) injec- Groups diam.
and tion com- shown
route of Cy Expts* pared (mm)
07i.p. 7 A 2,3 10
15
0 7i.v. 5 B, C 2, 4 10
15
07 i.p. a
007 i.v. 15J
B
Yes
or
No
No
No
Yes
Yes
Statistical evidence
"-
x2
(ld.f) P
1*14 >0-20
0-62 >0-40
10-83 0.001
16-70 <0 0005
2, 5 10 Yes 3-98 <005 2, ' 15 Yes 8-93 <0 005
O-1 i.t. 5 B 2, 6 10 No
15 No
0 7 i.t. 5 B 2, 7 10 No
15 No
0-7 i.p.
0-35 i.v.
0-7 i.v.
0-7 i.v.
+
03.5 i.v .
B
5)
150
8, 9 10 Yes 4-91 <0 05
15 Yes 7-75 <0-01
5 C 10, 11 15 Yes 3-93 <0 05
5.
15J
C 10, 12 15 Yes 4-48 <0-05
* For detailed results see Table V where they are similarly (lesignated. They are not the same as Expts.
A, B, C of Table II.
It will be seen that a single i.p. injection
of Cy in a dosage of 200 mg/kg body wt
to mice bearing transplants of tumour
W54 which had attained a diameter of 5
or 9 mm caused a marked but temporary
reduction in tumour size, following which
growth was resumed at much the same
rate as before (Fig. 1); the net effect was
therefore a significant delay in reaching
the diameters used as end-points in the
statistical analysis (Table IV and Table V,
Group 2). The addition of a single i.v.
injection of C. parvum 5 days after the Cy
potentiated the effect (Fig. 1) and this is
reflected in a further significant prolonga-
tion of the time required to attain the
chosen end-points (Table IV and Table V,
Groups 4 and 11). A second i.v. injection
of C. parvum 10 days after the first
(Table V, Group 12) added little or
nothing to this effect. An i.p. followed by
an i.v. injection of C. parvum also had a
marked effect (Table IV and Table V,
Group 5) but a single i.p. (Group 3) or i.t.
(Groups 6 and 7) injection was ineffective.
Repeated treatment with Cy, according
to a dose schedule which was chosen
primarily to avoid serious toxic effects and
is not necessarily optimal (Group 8), was
little if any more effective than a single
dose, but the addition of injections of
C. parvum interspersed between the injec-
tions of Cy (Fig. 2 and Table V, Group 9)
increased the therapeutic effect quite
markedly, to an extent comparable to that
observed in similar experiments with
transplants of a highly immunogenic
tumour (Fig. 3).
DISCUSSION
It has been reported previously that the
growth of isogenic transplants of highly
Treatment,
Mean
tumour
diam.
when
1st Cy
given
(mm)
4-5
Cy
(mg/kg)
iT).
200
200 followed
10 days later
by 50
200
350
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FIG. 1.- Effect of a single injection of cyclophosphamide (Cy) followed by a single injection of C.
parvum on the growth of established transplants of spontaneous tumour W54. The vertical bars
denote ± s.e. A A A, controls, no treatment; 0 0, Cy 200 mg/kg i.p. Day 17;
0 *, Cy 200 mg/kg i.p. Day 17 + C. parvum 0 7 mg i.v. Day 22.
E
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Fi(;. 2. Effect of repeated injection ofCy and C. parvum on the growth of established transplants of
spontaneous tumour W54. The vertical bars denote ± s.e. A A A, Controls, no treatmrent;
O O-I, Cy 200 mg/kg i.p. Day 12, and 50 mg/kg i.p. Days 22, 32; *, Cy 200 mg/
kg i.p. Day 12, and 50 mg/kg i.p. Days 22, 32 + C. parvum 0 7 mg i.p. Day 17, and 0 07 mg i.v.
Days 27, 37.
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Fio(8. 3. Effect of repeated injection of Cy and C. parvum on the growth of established transplanits
of a highly immunogenic methylcholanthrene-induced fibrosarcoma WI. A -A - A, Controls,
no treatment; C [] [, Cy 200 mg/kg i.p. Day 12 and 50mg/kg i.p. Days22, 32; * *,
Cy 200 mg/kg i.p. Day 12 andl 50 mg/kg i.p. Days 22, 32 + C. parvum 0 7 mg i.p. Day 17 and 0 07
mg i.v. Days 27, 37.
immunogenic methylcholanthrene-induced
murine fibrosarcomas in normal mice is
inhibited by i.v. or i.p. injection of C.
parvum a few days before or after tumour
inoculation, and also by mixing a small
dose of C. parvum with the tumour
inoculum or injecting it i.t. 3 days after
tumour inoculation, but not by s.c.
injection of C. parvum at a remote site
(Woodruffand Dunbar, 1973, 1975; Wood-
ruff, 1975; Woodruff and Whitehead,
1977). Further analysis has shown that
the therapeutic effect of i.v. and i.p.
injection of C. parvurn, and of mixing
C. parvum with the tumour-cell inoculum,
is well maintained in T-cell-deficient mice
(Woodruff et al., 1973; Woodruff and
Warner, 1977) and is consistent with the
hypothesis that it is due, to a substantial
extent, to activation of macrophages or
macrophage precursors (Woodruff, Ghaffar
and Whitehead, 1976), whereas the effect
ofi.t. injection ofC. parvum (except in the
special case in which the C. parvum is
mixed and injected with the tumour cells)
is highly T-cell dependent.
It seemed possible therefore that i.v. or
i.p. injection of C. parvum, and mixing
C. parvrum with the tumour-cell inoculum,
would also inhibit the growth of isogenic
transplants ofa non-immunogenic tumour,
and, according to Hewitt et al. (1976),
tumours "that arise in otherwise normal
low-cancer-strain mice which have re-
ceived no treatment which is calculated or
liable to induce cancer" are in general
non-immunogenic, and should therefore
provide a good model with which to test
this hypothesis.
The tumour (W54) used in the present
experiments certainly conforms to the
Hewitt et al. criterion of spontaneity, and
live challenge after pretreatment with
irradiated cells has failed to reveal any
evidence of immunogenicity. Live chal-
lenge after pretreatment with viable cells
followed by amputation, or with mito-
mycin-treated cells, has also revealed no
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change in the incidence of tumours, but
has revealed a modest but apparently
significant reduction in tumour growth
rate when the cell dose used for challenge
was relatively low. It seems reasonable
therefore to describe the tumour as
virtually non-immunogenic, though it may
well be not absolutely devoid of TSTA or
indeed of antigens with a rejection-
inducing potential in the autochthonous
host.
It is, in our view, an open question
whether the same qualification needs to
be applied to the tumours used by Hewitt
et al. (1976) and indeed to other opera-
tionally spontaneous tumours commonly
described as non-immunogenic. Our evi-
dence suggesting some degree of immuno-
genicity is based on 2 forms of pretreat-
ment, one of which (injection of
mitomycin-treated cells) was not used by
Hewitt et al., and the other which
(injection of viable cells followed by
amputation) was used by them to a very
limited extent. In studying the effect of
pretreatment with irradiated cells, which
in our experiments revealed no evidence of
immunogenicity, Hewitt et al. used what
might be regarded as a more refined test,
in that they compared the TD50 in pre-
treated and non-pretreated mice; it is
noteworthy however that, while the TD50
was never higher in the pretreated mice,
it was often lower, and the suggestion that
this might be due to immunological
enhancement and hence to tumour anti-
genicity, though dismissed by Hewitt
et al., cannot be excluded on the evidence
available. Even if this is not the case,
failure to immunize with irradiated cells
alone cannot be accepted as conclusive
evidence that a tumour is completely
non-immunogenic, since, as McKhann
(1964) has shown, weak transplantation
antigens (associated with the H-1 and H-3
loci in the mouse) may be destroyed by as
little as 400 rad irradiation, and it is an
open question whether the same is true
of weak TSTA.
Ifwe accept that our tumour is virtually
non-immunogenic, thepresentexperiments
have in the main confirmed our predic-
tion, and have shown that the effects of
i.v. injection of C. parvum after tumour
inoculation, and of the mixing procedure,
are of the same order of magnitude with
the immunogenic and non-immunogenic
tumours. These results are consistent with
the hypothesis that macrophages play a
role in surveillance against cancer, and
may function in this way even with non-
immunogenic tumours. The findings do
not however correspond exactly to those
obtained with a highly immunogenic
tumour, in that i.v. injection of C. parvum
before, and i.p. injection either before or
after, tumour inoculation was relatively
ineffective with the non-immunogenic
tumour. The reason for this difference is
the subject of further investigation.
It has also been reported previously that
i.p. injection of Cy, followed by i.v. or i.p.
injection ofC. parvum, was therapeutically
more effective against established trans-
plants of a highly immunogenic fibro-
sarcoma than injection of Cy alone
(Woodruff and Dunbar, 1973) and it has
now been shown that the same is true
with the non-immunogenic tumour of the
present experiments. This suggests that
the effect of C. parvum after reduction of
the tumour mass with Cy is also due, to a
substantial extent, to activation of macro-
phages, and further experiments have
been designed to test this hypothesis.
This last finding is not only of theoreti-
cal interest, but has the important
practical implication that systemic admin-
istration ofC. parvum may be oftherapeu-
tic value as an adjunct to chemotherapy
even in the case of tumours lacking
TSTA. It seems likely that this will be
true also ofotheragents, besides C.parvum,
which cause widespread activation of
macrophages, and it will be of interest to
determine whether this form of adjuvant
therapy is also effective with non-immuno-
genic tumours after reduction of the
tumour mass by surgical excision or
radiotherapy.
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